Low-concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ.

Aims To investigate the effect of switching to a different type of myopia control spectacles on myopia progression. Methods ...

Please provide your email address to receive an email when new articles are posted on . More than 90% of children with myopia experienced a decrease in progression with the use of NaturalVue ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Three studies showed that adults aged 20 to 50 years ...

Compared with placebo, low-dose atropine (0.01%) eyedrops may slow myopia (nearsightedness) progression and axial elongation in Chinese children with low and moderate myopia. It is estimated that by ...

Children and adolescents were at higher risk for myopic maculopathy progression if they had worse best-corrected visual acuity and longer axial length, among other risk factors. Myopic maculopathy ...

Low concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ ...

Vertical and horizontal relative peripheral refraction (RPR) are associated with faster axial length progression and higher risk of incident myopia, according to a study published online June 16 in ...

A prescription for bifocals may help children with rapidly worsening nearsightedness in maintaining better vision. Nearsightedness is particularly common among people of Asian descent, affecting up to ...

Glasses to stop myopia or nearsightedness in children have been shown to work in a multi-site trial of 256 children and will go on sale later this year outside the United States. The glasses are the ...

Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of ...